{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T21:20:38Z","timestamp":1778707238078,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T00:00:00Z","timestamp":1664928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T00:00:00Z","timestamp":1664928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Skin metastasis of ovarian cancer is extremely rare. We report an unusual case of ovarian carcinosarcoma with cutaneous metastasis of carcinomatous component that displayed distinct clinical manifestation. A 48-year-old woman presented to the dermatologist complaining of a new onset of erythematous, plaque-like skin rash with multiple small nodules on the left inner thigh, the area measuring 8\u2009\u00d7\u20095cm. While the patient had no history of dermatologic conditions, she underwent a total hysterectomy and bilateral salpingo-oophorectomy, omentectomy, and lymph node dissection 16 months ago with a pathology confirmed stage IIIC ovarian carcinosarcoma. Of note, the carcinomatous component, mainly adenocarcinoma with hybrid features of seromucinous, endometrioid and minor high-grade serous carcinoma, involved bilateral fallopian tubes, omentum, and parametrium with extensive lymph node metastases. A skin biopsy specimen revealed an adenocarcinoma involving epidermis, dermis, and subcutaneous tissue with nodular contours, consistent with metastatic carcinomatous component of carcinosarcoma. Both carcinomatous component of primary ovarian carcinosarcoma and metastatic adenocarcinoma in the skin demonstrated Pax8, WT-1, and ER positivity and a mutation pattern of p53. The patient passed away 15 months after identification of skin metastasis. This case represents a unique example of cutaneous metastasis of ovarian carcinosarcoma with distinct clinical manifestation and detailed histopathological description. Alertness to the possibility of cutaneous metastasis, in combination with clinical history, morphological and immunohistochemical findings, is critical for a definitive classification.<\/jats:p>","DOI":"10.1186\/s13000-022-01256-x","type":"journal-article","created":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T11:10:12Z","timestamp":1664968212000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Cutaneous metastasis of carcinomatous component of ovarian carcinosarcoma: A case report and review of the literature"],"prefix":"10.1186","volume":"17","author":[{"given":"Jinhang","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhifeng","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deyin","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aijun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,5]]},"reference":[{"key":"1256_CR1","volume-title":"WHO Classification of Tumors of Female Reproductive Organs","author":"RJ Kurman","year":"2014","unstructured":"Kurman RJ, Carcangiu ML, Herrington CS, et al. WHO Classification of Tumors of Female Reproductive Organs. Lyon: IARC; 2014."},{"key":"1256_CR2","first-page":"114","volume":"1","author":"H Fujii","year":"2000","unstructured":"Fujii H, Yoshida M, Gong ZX, et al. Frequent genetic heterogeneity in the clonal evolution of gynecological carcinosarcoma and its influence on phenotypic diversity. Cancer Res Jan. 2000;1:60:114\u201320.","journal-title":"Cancer Res Jan"},{"key":"1256_CR3","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1097\/00004347-200207000-00010","volume":"21","author":"A Gallardo","year":"2002","unstructured":"Gallardo A, Matias-Guiu X, Lagarda H, et al. Malignant mullerian mixed tumor arising from ovarian serous carcinoma: a clinicopathologic and molecular study of two cases. Int J Gynecol Pathol Jul. 2002;21:268\u201372.","journal-title":"Int J Gynecol Pathol Jul"},{"key":"1256_CR4","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/01.pgp.0000092134.88121.56","volume":"22","author":"Z Jin","year":"2003","unstructured":"Jin Z, Ogata S, Tamura G, et al. Carcinosarcomas (malignant mullerian mixed tumors) of the uterus and ovary: a genetic study with special reference to histogenesis. Int J Gynecol Pathol Oct. 2003;22:368\u201373.","journal-title":"Int J Gynecol Pathol Oct"},{"key":"1256_CR5","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/(SICI)1096-9896(199712)183:4<424::AID-PATH949>3.0.CO;2-L","volume":"183","author":"EC Abeln","year":"1997","unstructured":"Abeln EC, Smit VT, Wessels JW, et al. Molecular genetic evidence for the conversion hypothesis of the origin of malignant mixed mullerian tumours. J Pathol Dec. 1997;183:424\u201331.","journal-title":"J Pathol Dec"},{"key":"1256_CR6","doi-asserted-by":"publisher","first-page":"12238","DOI":"10.1073\/pnas.1614120113","volume":"25","author":"S Zhao","year":"2016","unstructured":"Zhao S, Bellone S, Lopez S, et al. Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition. Proc Natl Acad Sci U S A Oct. 2016;25:113:12238\u201343.","journal-title":"Proc Natl Acad Sci U S A Oct"},{"key":"1256_CR7","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.ygyno.2011.02.023","volume":"1","author":"JA Rauh-Hain","year":"2011","unstructured":"Rauh-Hain JA, Growdon WB, Rodriguez N, et al. Carcinosarcoma of the ovary: a case-control study. Gynecol Oncol Jun. 2011;1:121:477\u201381.","journal-title":"Gynecol Oncol Jun"},{"key":"1256_CR8","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1002\/1097-0142(19871001)60:7<1561::AID-CNCR2820600725>3.0.CO;2-V","volume":"1","author":"J Dauplat","year":"1987","unstructured":"Dauplat J, Hacker NF, Nieberg RK, et al. Distant metastases in epithelial ovarian carcinoma. Cancer Oct. 1987;1:60:1561\u20136.","journal-title":"Cancer Oct"},{"key":"1256_CR9","doi-asserted-by":"publisher","first-page":"e7798","DOI":"10.1097\/MD.0000000000007798","volume":"96","author":"I Otsuka","year":"2017","unstructured":"Otsuka I, Matsuura T. Skin metastases in epithelial ovarian and fallopian tube carcinoma. Med (Baltimore) Aug. 2017;96:e7798.","journal-title":"Med (Baltimore) Aug"},{"key":"1256_CR10","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/S0090-8258(03)00400-1","volume":"90","author":"G Cormio","year":"2003","unstructured":"Cormio G, Capotorto M, Di Vagno G, et al. Skin metastases in ovarian carcinoma: a report of nine cases and a review of the literature. Gynecol Oncol Sep. 2003;90:682\u20135.","journal-title":"Gynecol Oncol Sep"},{"key":"1256_CR11","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1111\/IGC.0b013e3181a416d0","volume":"19","author":"B Cheng","year":"2009","unstructured":"Cheng B, Lu W, Xiaoyun W, et al. Extra-abdominal metastases from epithelial ovarian carcinoma: an analysis of 20 cases. Int J Gynecol Cancer May. 2009;19:611\u20134.","journal-title":"Int J Gynecol Cancer May"},{"key":"1256_CR12","first-page":"427","volume":"1","author":"V Sibaud","year":"2016","unstructured":"Sibaud V, Leboeuf NR, Roche H, et al. Dermatological adverse events with taxane chemotherapy. Eur J Dermatol Oct. 2016;1:26:427\u201343.","journal-title":"Eur J Dermatol Oct"},{"key":"1256_CR13","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s11882-014-0451-7","volume":"14","author":"J Caiado","year":"2014","unstructured":"Caiado J, Picard M. Diagnostic tools for hypersensitivity to platinum drugs and taxanes: skin testing, specific IgE, and mast cell\/basophil mediators. Curr Allergy Asthma Rep Aug. 2014;14:451.","journal-title":"Curr Allergy Asthma Rep Aug"},{"key":"1256_CR14","doi-asserted-by":"publisher","first-page":"110502","DOI":"10.1016\/j.biopha.2020.110502","volume":"129","author":"I Holynska-Iwan","year":"2020","unstructured":"Holynska-Iwan I, Sobiesiak M. Cisplatin influences the skin ion transport - An in vitro study. Biomed Pharmacother Sep. 2020;129:110502.","journal-title":"Biomed Pharmacother Sep"},{"key":"1256_CR15","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/0190-9622(93)70173-Q","volume":"29","author":"DP Lookingbill","year":"1993","unstructured":"Lookingbill DP, Spangler N, Helm KF. Cutaneous metastases in patients with metastatic carcinoma: a retrospective study of 4020 patients. J Am Acad Dermatol Aug. 1993;29:228\u201336.","journal-title":"J Am Acad Dermatol Aug"},{"key":"1256_CR16","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1002\/1097-0142(197205)29:5<1298::AID-CNCR2820290526>3.0.CO;2-6","volume":"29","author":"MH Brownstein","year":"1972","unstructured":"Brownstein MH, Helwig EB. Metastatic tumors of the skin. Cancer May. 1972;29:1298\u2013307.","journal-title":"Cancer May"},{"key":"1256_CR17","first-page":"11","volume":"2","author":"I Otsuka","year":"2019","unstructured":"Otsuka I. Cutaneous Metastases in Ovarian Cancer. Cancers (Basel) Sep. 2019;2:11.","journal-title":"Cancers (Basel) Sep"},{"key":"1256_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00004347-199001000-00001","volume":"9","author":"SG Silverberg","year":"1990","unstructured":"Silverberg SG, Major FJ, Blessing JA, et al. Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus. A Gynecologic Oncology Group pathologic study of 203 cases. Int J Gynecol Pathol. 1990;9:1\u201319.","journal-title":"Int J Gynecol Pathol"},{"key":"1256_CR19","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1097\/PAS.0b013e31824ee500","volume":"36","author":"J Kunkel","year":"2012","unstructured":"Kunkel J, Peng Y, Tao Y, et al. Presence of a sarcomatous component outside the ovary is an adverse prognostic factor for primary ovarian malignant mixed mesodermal\/mullerian tumors: a clinicopathologic study of 47 cases. Am J Surg Pathol Jun. 2012;36:831\u20137.","journal-title":"Am J Surg Pathol Jun"},{"key":"1256_CR20","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.gynor.2012.07.003","volume":"2","author":"AC Wiechert","year":"2012","unstructured":"Wiechert AC, Garrett LA, Lin G, et al. Management of a skin metastasis in a patient with advanced ovarian cancer. Gynecol Oncol Case Rep. 2012;2:124\u20136.","journal-title":"Gynecol Oncol Case Rep"},{"key":"1256_CR21","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1111\/j.1365-4632.2010.04485.x","volume":"49","author":"H Husein-ElAhmed","year":"2010","unstructured":"Husein-ElAhmed H, Aneiros-Fernandez J, Arias-Santiago S, et al. Sister Mary Joseph\u2019s nodule as a metastasis of ovarian adenocarcinoma. Int J Dermatol Sep. 2010;49:1045\u20136.","journal-title":"Int J Dermatol Sep"},{"key":"1256_CR22","doi-asserted-by":"publisher","first-page":"e28712","DOI":"10.1097\/MD.0000000000028712","volume":"11","author":"X Nie","year":"2022","unstructured":"Nie X, Chen X, Jiang Y, et al. Sister Mary Joseph nodule as cutaneous manifestations of metastatic ovarian cancer: A case report and review of the literature. Med (Baltimore) Feb. 2022;11:101:e28712.","journal-title":"Med (Baltimore) Feb"},{"key":"1256_CR23","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S0360-3016(03)01561-X","volume":"1","author":"M Callister","year":"2004","unstructured":"Callister M, Ramondetta LM, Jhingran A, et al. Malignant mixed Mullerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome. Int J Radiat Oncol Biol Phys Mar. 2004;1:58:786\u201396.","journal-title":"Int J Radiat Oncol Biol Phys Mar"},{"key":"1256_CR24","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1097\/DAD.0000000000000476","volume":"38","author":"M Clairwood","year":"2016","unstructured":"Clairwood M, Yasuda M, Belazarian L, et al. Unusual Cutaneous Metastasis of Uterine Carcinosarcoma: A Case Report and Review of the Literature. Am J Dermatopathol May. 2016;38:366\u20139.","journal-title":"Am J Dermatopathol May"},{"key":"1256_CR25","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1111\/j.1600-0560.2010.01564.x","volume":"37","author":"M Fujiwara","year":"2010","unstructured":"Fujiwara M, Taube J, Sharma M, et al. PAX8 discriminates ovarian metastases from adnexal tumors and other cutaneous metastases. J Cutan Pathol Sep. 2010;37:938\u201343.","journal-title":"J Cutan Pathol Sep"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-022-01256-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-022-01256-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-022-01256-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T11:12:55Z","timestamp":1664968375000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-022-01256-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,5]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1256"],"URL":"https:\/\/doi.org\/10.1186\/s13000-022-01256-x","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,5]]},"assertion":[{"value":"6 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study has been approved by the Ethics Committee of PLA General Hospital (No. 2022\u2009\u2212\u2009105).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of their clinical details and\/or clinical images was obtained from the relative of the patient (the patient passed away). A copy of the consent form is available for review by the Editor of this journal.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"76"}}